AI重塑决策逻辑,医渡方案助力新药立项提质增效

砍柴网
17 Jul

医药行业的创新突围,始于新药立项的科学决策。随着 AI 技术的成熟,这一核心命题迎来全新解法:医渡科技以AI赋能的新药立项可行性解决方案推动药企实现立项决策升级。新药立项的三大困局:效率、客观性与成本之痛新药立项作为新药研发的起点,直接决定着研发方向与最终成败,是药品生产企业的核心关注焦点。这一环节需要覆盖从疾病领域到靶点选择、新药研发再到临床验证的全链条考量,本质上是一场专业度极高的“信息攻坚战...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10